Schonfeld Strategic Advisors’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-11,920
| Closed | -$367K | – | 2128 |
|
2021
Q3 | $367K | Sell |
11,920
-720
| -6% | -$22.2K | ﹤0.01% | 1348 |
|
2021
Q2 | $411K | Buy |
12,640
+1,253
| +11% | +$40.7K | ﹤0.01% | 1247 |
|
2021
Q1 | $431K | Buy |
+11,387
| New | +$431K | 0.01% | 1157 |
|
2020
Q4 | – | Sell |
-1,800
| Closed | -$58K | – | 1637 |
|
2020
Q3 | $58K | Sell |
1,800
-9,819
| -85% | -$316K | ﹤0.01% | 1262 |
|
2020
Q2 | $511K | Buy |
+11,619
| New | +$511K | 0.01% | 755 |
|
2018
Q3 | – | Sell |
-6,733
| Closed | -$589K | – | 869 |
|
2018
Q2 | $589K | Buy |
6,733
+3,150
| +88% | +$276K | 0.03% | 504 |
|
2018
Q1 | $693K | Buy |
+3,583
| New | +$693K | 0.05% | 404 |
|